Search Videos by Topic or Participant
Browse by Series:

Introduction: Understanding ALL and Its Prognostic Factors

Panelists: Dan Douer, MD, MSK; Richard M. Harris, MD, Cedars Sinai; Jeffrey Lancet, MD, Moffitt; Mark R. Litzow, MD, Mayo Clinic; Leonard S. Sender
Published: Friday, Jan 09, 2015
For High-Definition, Click
Moderator Leonard S. Sender, MD, clinical professor of medicine at the School of Medicine University of California, Irvine, facilitates a discussion about the key prognostic factors in Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). Mark R. Litzow, MD, professor of medicine at the College of Medicine, Mayo Clinic in Rochester, Minnesota, lists some of the more commonly recognized prognostic factors, including age and cytogenetics. In addition, Litzow touches on the use of minimal residual disease (MRD) and various genetic mutations as emerging prognostic tools.
Slider Left
Slider Right
For High-Definition, Click
Moderator Leonard S. Sender, MD, clinical professor of medicine at the School of Medicine University of California, Irvine, facilitates a discussion about the key prognostic factors in Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). Mark R. Litzow, MD, professor of medicine at the College of Medicine, Mayo Clinic in Rochester, Minnesota, lists some of the more commonly recognized prognostic factors, including age and cytogenetics. In addition, Litzow touches on the use of minimal residual disease (MRD) and various genetic mutations as emerging prognostic tools.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x